Laboratorios Farmaceuticos Rovi. 

0
454
+$0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

19%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
859.14MRevenue
163.27MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LRVIY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap292.35B
Novartis is a global healthcare company that directly competes with Rovi in the pharmaceuticals sector, offering a wide range of drugs that could overlap with Rovi's product offerings.
Pfizer
PFE
Mkt Cap159.36B
Pfizer is a large pharmaceutical company with a broad product portfolio that competes in various therapeutic areas with Rovi, including biosimilars and innovative drugs.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline is a global healthcare company that competes with Rovi in the development and marketing of pharmaceuticals and vaccines.
Merck
MRK
Mkt Cap366B
Merck & Co., known as MSD outside the United States and Canada, offers a wide range of pharmaceutical products that compete with Rovi's offerings, especially in the areas of health care and vaccines.
Sanofi
SNY
Mkt Cap107.39B
Sanofi is a global biopharmaceutical company focused on human health, directly competing with Rovi in several therapeutic areas, including cardiovascular and diabetes.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie operates in the global pharmaceutical industry, offering products that compete with Rovi, particularly in the areas of immunology and oncology.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company with a wide range of products that compete with Rovi in several key areas, including respiratory and cardiovascular diseases.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb is a global biopharmaceutical company whose products compete with Rovi in the areas of cardiovascular, oncology, and immunoscience.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson is a diverse healthcare company that competes with Rovi through its pharmaceutical division, offering products in immunology, infectious diseases, and other areas.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.46B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, competing with Rovi in the generic drug market and in the development of specialty pharmaceuticals.

About

LABORATORIOS FARMACEUTICO
Show more...
CEO
Juan Lopez-Belmonte Encina
Employees
2232
Country
Spain
ISIN
US50540X1090

Listings

0 Comments

Share your thoughts

FAQ

What is Laboratorios Farmaceuticos Rovi. stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Laboratorios Farmaceuticos Rovi. stocks are traded under the ticker LRVIY.
When is the next Laboratorios Farmaceuticos Rovi. earnings date?
Laboratorios Farmaceuticos Rovi. is going to release the next earnings report on November 05, 2026.
What is Laboratorios Farmaceuticos Rovi. revenue for the last year?
Laboratorios Farmaceuticos Rovi. revenue for the last year amounts to 859.14M USD.
What is Laboratorios Farmaceuticos Rovi. net income for the last year?
LRVIY net income for the last year is 163.27M USD.
How many employees does Laboratorios Farmaceuticos Rovi. have?
As of September 06, 2026, the company has 2,232 employees.
In which sector is Laboratorios Farmaceuticos Rovi. located?
Laboratorios Farmaceuticos Rovi. operates in the Health & Wellness sector.
When did Laboratorios Farmaceuticos Rovi. complete a stock split?
Laboratorios Farmaceuticos Rovi. has not had any recent stock splits.
Where is Laboratorios Farmaceuticos Rovi. headquartered?
Laboratorios Farmaceuticos Rovi. is headquartered in Pozuelo de Alarcón, Spain.